Form 8-K - Current report:
SEC Accession No. 0001193125-20-286273
Filing Date
2020-11-05
Accepted
2020-11-05 08:11:02
Documents
13
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d39718d8k.htm   iXBRL 8-K 24854
2 EX-99.1 d39718dex991.htm EX-99.1 66291
  Complete submission text file 0001193125-20-286273.txt   221435

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20201105.xsd EX-101.SCH 3102
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20201105_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20201105_pre.xml EX-101.PRE 11429
6 EXTRACTED XBRL INSTANCE DOCUMENT d39718d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 201288797
SIC: 2834 Pharmaceutical Preparations